Clinical Trial Update: Pilot Study Evaluating the Efficacy and Safety of Metformin in Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial evaluating the efficacy and safety of metformin in melanoma has completed. The study focused on patients with metastatic disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Metastatic Melanoma (Stage IIIC Non-résécable or no Surgically Curable or Stage IV With Classification AJCC) | Phase 2 | Status: COMPLETED